249 related articles for article (PubMed ID: 34019288)
21. Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.
Valsesia-Wittmann S; Magdeleine M; Dupasquier S; Garin E; Jallas AC; Combaret V; Krause A; Leissner P; Puisieux A
Cancer Cell; 2004 Dec; 6(6):625-30. PubMed ID: 15607966
[TBL] [Abstract][Full Text] [Related]
22. Oncogene-mediated transformation of fetal rat colon in vitro.
Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
[TBL] [Abstract][Full Text] [Related]
23. Generation of a Tetracycline Regulated Mouse Model of MYC-Induced T-Cell Acute Lymphoblastic Leukemia.
Mahauad-Fernandez WD; Rakhra K; Felsher DW
Methods Mol Biol; 2021; 2318():297-312. PubMed ID: 34019298
[TBL] [Abstract][Full Text] [Related]
24. Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif.
Thomas LR; Foshage AM; Weissmiller AM; Popay TM; Grieb BC; Qualls SJ; Ng V; Carboneau B; Lorey S; Eischen CM; Tansey WP
Oncogene; 2016 Jul; 35(27):3613-8. PubMed ID: 26522729
[TBL] [Abstract][Full Text] [Related]
25. Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus.
Fulton R; Gallagher R; Crouch D; Neil JC
J Virol; 1996 Feb; 70(2):1154-62. PubMed ID: 8551576
[TBL] [Abstract][Full Text] [Related]
26. Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach.
Samy MD; Yavorski JM; Mauro JA; Blanck G
Cell Cycle; 2016 Jun; 15(12):1572-8. PubMed ID: 27074591
[TBL] [Abstract][Full Text] [Related]
27. Myc: a weapon of mass destruction.
Secombe J; Pierce SB; Eisenman RN
Cell; 2004 Apr; 117(2):153-6. PubMed ID: 15084254
[TBL] [Abstract][Full Text] [Related]
28. Stem cell-specific activation of an ancestral myc protooncogene with conserved basic functions in the early metazoan Hydra.
Hartl M; Mitterstiller AM; Valovka T; Breuker K; Hobmayer B; Bister K
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4051-6. PubMed ID: 20142507
[TBL] [Abstract][Full Text] [Related]
29. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants.
Mukherjee B; Morgenbesser SD; DePinho RA
Genes Dev; 1992 Aug; 6(8):1480-92. PubMed ID: 1644290
[TBL] [Abstract][Full Text] [Related]
30. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.
Salghetti SE; Kim SY; Tansey WP
EMBO J; 1999 Feb; 18(3):717-26. PubMed ID: 9927431
[TBL] [Abstract][Full Text] [Related]
31. MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation.
Stojanova A; Tu WB; Ponzielli R; Kotlyar M; Chan PK; Boutros PC; Khosravi F; Jurisica I; Raught B; Penn LZ
Cell Cycle; 2016 Jul; 15(13):1693-705. PubMed ID: 27267444
[TBL] [Abstract][Full Text] [Related]
32. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
[TBL] [Abstract][Full Text] [Related]
33. MYB and MYC in the cell cycle.
Bishop JM; Eilers M; Katzen AL; Kornberg T; Ramsay G; Schirm S
Cold Spring Harb Symp Quant Biol; 1991; 56():99-107. PubMed ID: 1819523
[No Abstract] [Full Text] [Related]
34. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
Husain Z; FitzGerald GB; Wick MM
J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
[TBL] [Abstract][Full Text] [Related]
35. MYC activation is a hallmark of cancer initiation and maintenance.
Gabay M; Li Y; Felsher DW
Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890832
[TBL] [Abstract][Full Text] [Related]
36. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R
Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide sequence of the CMII v-myc allele.
Walther N; Jansen HW; Trachmann C; Bister K
Virology; 1986 Oct; 154(1):219-23. PubMed ID: 3019003
[TBL] [Abstract][Full Text] [Related]
38. Myc oncogenes: the enigmatic family.
Ryan KM; Birnie GD
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):713-21. PubMed ID: 8615760
[TBL] [Abstract][Full Text] [Related]
39. Cell-Based Methods for the Identification of Myc-Inhibitory Small Molecules.
Burkhart CA; Haber M; Norris MD; Gudkov AV; Nikiforov MA
Methods Mol Biol; 2021; 2318():337-346. PubMed ID: 34019301
[TBL] [Abstract][Full Text] [Related]
40. Examining Myc-Dependent Translation Changes in Cellular Homeostasis and Cancer.
Kovalski JR; Xu Y; Ruggero D
Methods Mol Biol; 2021; 2318():255-266. PubMed ID: 34019295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
